COFCO Biotechnology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Cash & Equivalents	2,518	1,909	1,481	1,017	1,116	662.33
Trading Asset Securities	-	-	-	3.82	1.86	-
Cash & Short-Term Investments	2,518	1,909	1,481	1,020	1,118	662.33
Cash Growth	51.00%	28.91%	45.14%	-8.71%	68.77%	-5.54%
Accounts Receivable	1,277	1,277	1,124	1,370	1,189	886.37
Other Receivables	114.99	114.69	196	168.42	293.76	456.98
Receivables	1,392	1,392	1,320	1,538	1,483	1,343
Inventory	2,122	2,770	2,534	3,763	4,052	4,991
Other Current Assets	626.94	739.34	700.37	1,349	982.02	2,904
Total Current Assets	6,659	6,810	6,035	7,671	7,635	9,901
Property, Plant & Equipment	8,671	8,590	8,632	8,611	8,515	8,494
Long-Term Investments	457.33	548.06	535.39	536.93	512.12	517.34
Goodwill	366.04	366.04	366.04	366.04	366.04	366.04
Other Intangible Assets	627.63	601.01	601.15	609.08	628.96	851.65
Long-Term Deferred Tax Assets	291.21	280.07	265.01	193.49	202.99	133.31
Long-Term Deferred Charges	40.56	40.99	41.94	31.31	25.23	22.22
Other Long-Term Assets	71.8	93.07	80.94	110.52	171.76	198.8
Total Assets	17,184	17,329	16,558	18,129	18,057	20,484
Accounts Payable	592.84	728.36	766.49	919.59	920.25	845.8
Accrued Expenses	151.04	250.81	262.96	360.15	418.44	499.97
Short-Term Debt	2,104	4,000	3,217	2,874	2,764	6,595
Current Portion of Long-Term Debt	54.66	61.41	44.93	42.67	86.61	45.71
Current Portion of Leases	-	17.95	19.18	12.08	20.81	-
Current Income Taxes Payable	76.07	46.57	47.59	61.58	35	71.42
Current Unearned Revenue	217.38	223.88	266.39	278.73	328.64	364.89
Other Current Liabilities	707.24	507.86	517.47	612.33	1,015	901.02
Total Current Liabilities	3,903	5,837	5,142	5,162	5,589	9,323
Long-Term Debt	1,826	165.1	165.65	191.28	406.4	189.7
Long-Term Leases	166.34	177.11	196.64	105.63	117.3	-
Long-Term Unearned Revenue	99.47	99.73	70.01	72.6	113.79	92.77
Long-Term Deferred Tax Liabilities	50.72	66.39	89	60.89	32.07	21.86
Other Long-Term Liabilities	73.44	67.8	41.19	27.33	43.32	55.02
Total Liabilities	6,119	6,413	5,704	5,619	6,302	9,683
Common Stock	1,856	1,860	1,865	1,865	1,866	1,866
Additional Paid-In Capital	6,090	6,102	6,126	6,135	6,131	6,127
Retained Earnings	1,949	1,810	1,784	3,449	2,847	1,839
Treasury Stock	-	-13.2	-33.31	-43.03	-66.89	-88.86
Comprehensive Income & Other	767.95	760.14	709.5	692.84	616.89	651.17
Total Common Equity	10,663	10,518	10,452	12,098	11,394	10,394
Minority Interest	402.32	398.22	401.96	411.53	361.42	408.12
Shareholders' Equity	11,065	10,916	10,854	12,510	11,755	10,802
Total Liabilities & Equity	17,184	17,329	16,558	18,129	18,057	20,484
Total Debt	4,150	4,421	3,643	3,226	3,395	6,830
Net Cash (Debt)	-1,633	-2,512	-2,162	-2,206	-2,278	-6,168
Net Cash Per Share	-0.87	-1.35	-1.17	-1.19	-1.23	-3.33
Filing Date Shares Outstanding	1,856	1,860	1,865	1,865	1,866	1,866
Total Common Shares Outstanding	1,856	1,860	1,865	1,865	1,866	1,866
Working Capital	2,756	973.45	893.51	2,509	2,046	578.01
Book Value Per Share	5.74	5.66	5.60	6.49	6.11	5.57
Tangible Book Value	9,669	9,551	9,484	11,123	10,399	9,176
Tangible Book Value Per Share	5.21	5.14	5.09	5.96	5.57	4.92
Buildings	-	4,530	4,447	4,678	4,534	-
Machinery	-	9,785	9,495	9,830	9,025	-
Construction In Progress	-	350.05	312.19	84.39	720.9	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.